OXFORD SCIENCE ENTERPRISES PLC - Profile & Financials

Accounts Submitted 6 May 2025

Confirmation Statement Submitted 23 Jun 2025

Net assets £1081.47M £58.19M 2024 year on year

Total assets £1191.53M £72.03M 2024 year on year

Total Liabilities £110.06M £13.83M 2024 year on year

Charges 2

2 outstanding

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

46 Woodstock Road Oxford OX2 6HT United Kingdom

Telephone

0186 595 0000

Website

oxfordscienceenterprises.com

Credit Report

Discover OXFORD SCIENCE ENTERPRISES PLC's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Period 1 Jan → 31 Dec 2024

Type Total Exemption Full

Next accounts 31 December 2025

Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

£183.06M

Decreased by £79.06M (-30%)

Net Assets

£1081.47M

Decreased by £58.19M (-5%)

Total Liabilities

£110.06M

Decreased by £13.83M (-11%)

Turnover

-£46.16M

Increased by £68.75M (+60%)

Employees

Increased by 4 (+6%)

Debt Ratio

Decreased by 1 (-10%)

Financial History

Revenue, profit, EBITDA and key financial figures

	2024 Dec Year End	2023 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share allotments and capital structure

14 Allotments 364,735,999 Shares £409.09m Total

Date From	Share Class	Shares Allotted	Amount Raised	Price/Share
25 Mar 2024	ORDINARY	51,333	£513.33	£0.01
18 Mar 2019	ORDINARY	3,000,000	£3.60m	£1.2
24 Oct 2018	ORDINARY	4,166,667	£5.00m	£1.2
5 Mar 2018	ORDINARY	1,666,668	£2.00m	£1.2
4 Jul 2017	ORDINARY	21,536,665	£25.84m	£1.2

Officers

11 active 16 resigned

Show resigned officers

						Status
Andre Crawford Brunt	Director	British	United Kingdom	54	14 Feb 2020	Active
Athene Eliana Georgina Blakeman	Secretary	Unknown	Unknown	—	25 Jan 2022	Active
Bernard John Taylor	Director	British	England	69	1 Jun 2015	Active
Christopher Michael Chambers	Director	British	England	64	1 Jun 2015	Active
Edward Martin Bussey	Director	British	United Kingdom	58	1 Sept 2023	Active
Fiona Elizabeth Murray	Director	British	United States	57	14 May 2024	Active
Jack Cemlyn Edmondson	Director	British	United Kingdom	48	1 Sept 2023	Active
James Henry Wilkinson	Director	British	United Kingdom	60	17 Nov 2015	Active

Shareholders

Shareholders (118)


Winterflood Client Nominees Limited <oxfdinst>	17.7%	139,421,996	Ordinary	23 Jun 2025
Vidacos Nominees Limited <158771>	0.4%	3,193,376	Ordinary	23 Jun 2025
Vidacos Nominees Limited <158772>	0.0%	199,000	Ordinary	23 Jun 2025

Persons with Significant Control

Persons with Significant Control (0)

No PSC information available

Group Structure

OXFORD SCIENCE ENTERPRISES PLC Current Company

1715 LABS LIMITED united kingdom shares 25 to 50 percent, voting rights 25 to 50 percent

ACIONNA THERAPEUTICS LTD united kingdom shares 50 to 75 percent, voting rights 50 to 75 percent

ALETHIO THERAPEUTICS LIMITED united kingdom shares 50 to 75 percent, voting rights 25 to 50 percent

ALLOYED LIMITED united kingdom shares 25 to 50 percent, voting rights 25 to 50 percent

AMBER THERAPEUTICS HOLDINGS LIMITED united kingdom shares 25 to 50 percent, voting rights 25 to 50 percent

ANIMAL DYNAMICS LIMITED united kingdom shares 50 to 75 percent, voting rights 50 to 75 percent

ARCHANGEL LIGHTWORKS LTD united kingdom shares 25 to 50 percent, voting rights 25 to 50 percent

ASCENSION EARTH RESOURCES LTD united kingdom shares 25 to 50 percent, voting rights 25 to 50 percent

BODLE TECHNOLOGIES LIMITED united kingdom shares 25 to 50 percent

CABLEFLUX TECHNOLOGIES LIMITED united kingdom shares 75 to 100 percent

CIRCADIAN THERAPEUTICS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent

CORA BIOSCIENCES LIMITED united kingdom shares 25 to 50 percent, voting rights 25 to 50 percent

CREDO THERAPIES LTD united kingdom shares 50 to 75 percent, voting rights 25 to 50 percent

DARK BLUE THERAPEUTICS LTD united kingdom shares 25 to 50 percent, voting rights 25 to 50 percent

DARK HORSE TECHNOLOGIES LTD united kingdom shares 25 to 50 percent, voting rights 25 to 50 percent

ENZBOND LIMITED united kingdom shares 50 to 75 percent, voting rights 50 to 75 percent, appoint/remove directors

EVOLITO LTD united kingdom voting rights 25 to 50 percent

EVOX THERAPEUTICS LIMITED united kingdom shares 25 to 50 percent, voting rights 25 to 50 percent

FLUOROK LIMITED united kingdom shares 25 to 50 percent, voting rights 25 to 50 percent

FRACTILE LTD united kingdom shares 25 to 50 percent, voting rights 25 to 50 percent

GROUND TRUTH LABS LTD united kingdom shares 25 to 50 percent, voting rights 25 to 50 percent

IOTA SCIENCES LIMITED united kingdom shares 50 to 75 percent, voting rights 25 to 50 percent

ISOGENIX LIMITED united kingdom shares 25 to 50 percent, voting rights 25 to 50 percent

KNEU HEALTH LIMITED united kingdom shares 25 to 50 percent, voting rights 25 to 50 percent

KODIFORM THERAPEUTICS LIMITED united kingdom shares 50 to 75 percent, voting rights 50 to 75 percent, appoint/remove directors

LIVING OPTICS LIMITED united kingdom shares 25 to 50 percent, voting rights 25 to 50 percent

MACROPHOX LTD united kingdom shares 50 to 75 percent, voting rights 25 to 50 percent

MARLEY HEALTH LTD united kingdom shares 25 to 50 percent, voting rights 25 to 50 percent

MATCHBIO LIMITED united kingdom shares 50 to 75 percent, significant influence or control as firm

METABOARDS LIMITED united kingdom shares 25 to 50 percent, voting rights 25 to 50 percent

MIXERGY LIMITED united kingdom shares 25 to 50 percent, voting rights 25 to 50 percent

MODE LABS LTD united kingdom shares 25 to 50 percent, voting rights 25 to 50 percent

NATURAL CAPITAL RESEARCH LIMITED united kingdom shares 25 to 50 percent

NAVENIO LIMITED united kingdom shares 25 to 50 percent, voting rights 25 to 50 percent

NOTOS MEDICAL LIMITED united kingdom voting rights 25 to 50 percent

NUCLEOME THERAPEUTICS LIMITED united kingdom voting rights 25 to 50 percent

ODQA RENEWABLE ENERGY TECHNOLOGIES LIMITED united kingdom shares 25 to 50 percent

OMASS THERAPEUTICS LIMITED united kingdom shares 25 to 50 percent, voting rights 25 to 50 percent

ORBIT DISCOVERY GROUP LTD united kingdom shares 25 to 50 percent, voting rights 25 to 50 percent

ORFONYX BIO LTD united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent

OSE LABS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

OSE MANAGER LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent

OSI MIDCO LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

OXFORD DATANOSTICS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

OXFORD NANOIMAGING LIMITED united kingdom shares 25 to 50 percent, voting rights 25 to 50 percent

OXFORD QUANTUM LIMITED united kingdom shares 75 to 100 percent

OXFORD SCIENCE ENTERPRISES HOLDINGS II LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

OXFORD SCIENCE ENTERPRISES HOLDINGS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

PROXISENSE LIMITED united kingdom shares 25 to 50 percent, voting rights 25 to 50 percent

REFEYN LTD united kingdom shares 25 to 50 percent, voting rights 25 to 50 percent

SELOXIUM LIMITED united kingdom shares 25 to 50 percent, voting rights 25 to 50 percent

SILVIS QUANTUM LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

SNOWFOX DISCOVERY LTD united kingdom shares 25 to 50 percent, voting rights 25 to 50 percent

SPYBIOTECH LIMITED united kingdom shares 25 to 50 percent, voting rights 25 to 50 percent

T-CYPHER BIO HOLDINGS LIMITED united kingdom shares 50 to 75 percent, voting rights 50 to 75 percent, appoint/remove directors

THELIOR BIO LIMITED united kingdom shares 50 to 75 percent, voting rights 50 to 75 percent

VIVID DX LIMITED united kingdom shares 25 to 50 percent, voting rights 25 to 50 percent

Charges

2 outstanding

Documents

Company Filings

Date	Category	Description	Document
21 Nov 2025	Officers	Appointment of Professor Frederick David Richard Hobbs as director on 2025-11-21	View(2 pages)
29 Sept 2025	Mortgage	Mortgage Create With Deed With Charge Number Charge Creation Date	View(29 pages)
14 Jul 2025	Resolution	Resolutions	View(2 pages)
23 Jun 2025	Confirmation Statement	Confirmation statement made on 2025-06-19 with updates	View(16 pages)
6 May 2025	Accounts	Annual accounts made up to 2024-12-31	View(134 pages)